All News

Bill Schimmel, CEO and executive director of the Pharmacy Technician Certification Board (PTCB), discusses why pharmacy technicians are leaving the profession and why they are staying.

Students from the Daniel K. Inouye College of Pharmacy discuss their experience at the University of Hawaii.

Predictably, patients in underserved rural, urban communities will face challenges gaining access to approved study sites.

The FDA approved Azurity Pharmaceutical’s omeprazole and sodium bicarbonate for oral suspension to treat benign gastric ulcers and it is predicted to reach commercial markets by next year.

Another market innovation continues the bifurcation of the profession's practice as community pharmacies become generics businesses.

Patients who had previously hit their out-of-pocket maximums could see a significant change.

AI-based technologies are increasingly being used for things such as virtual screening, physics-based biological activity assessment, and drug crystal-structure prediction.

Therapeutic drug monitoring is essential with tacrolimus, which is one of the key immunosuppressive agents used after solid organ transplant.

Researchers suggest that more public health measures should be taken to address disparities among adults boosted for COVID-19.

The COVID-19 pandemic impacted people experiencing homeless, though estimates remain unknown and highlights a need for more inclusive data.

The 2022 Biosimilar Survey signaled that most pharmacists are willing to incorporate biosimilars into their formularies, but certain factors are preventing widespread adoption.

Speaking your voice through Ted and TedX is one way to truly spread awareness of what you believe in as a health care professional.

DNA and RNA sequencing could provide insight about resistance to chemotherapy in patients suffering from triple-negative breast cancer.

Test can evaluate whether a patient with lymphoma will respond to CAR T-cell therapy, which could lead to better and longer lasting treatment options.

Statins have been found to moderately benefit patients with cardiovascular disease risk factors, but researchers found socioeconomic disparities among those treated with statins.

Addiction to checking the news can worsen mental and physical illness, and in many cases may require individuals to reduce, or even stop, consuming any news.

Research indicates that there is a growing amount of unusual hepatitis cases in children throughout Europe.

Very short sleep among adolescents linked to a more than 70% increased risk of obesity/overweight in children, compared to those who get optimal 8 hours.

Memantine HCl (Namenda) is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.

Doan’s magnesium salicylate tetrahydrate formulation treats pain from backaches.

Pharmacists can help by preventing and treating opioid use disorder and overdoses.

School-aged children that self-swabbed for COVID-19 did so with almost as much accuracy as a health care provider, which could ease strain on school health care systems.

The phase 2 AXIOMATIC trials assessing milvexian met its primary endpoints, with researchers anticipating a phase 3 trial to come within the year.

Scott Biggs and Doug Long of IQVIA discussed where the pharmacy industry stands now and what they predict for the future.

An overview of the legal and business tools available to community, specialty, hospital, and health-system pharmacies in seeking to maintain payer network access and combat abusive practices.

It is not a leap to think that the 2022-2023 season could be worse than the past 2 seasons.

Although it may not have immediate significant impacts for many patients, the Inflation Reduction Act could open the door for future changes.

Rina Shah, PharmD, discussed the growing role for pharmacists in encouraging holistic health and wellness for patients.